King Wealth Management Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,379
Closed -$205K 163
2024
Q4
$205K Buy
+2,379
New +$257K 0.03% 148
2024
Q3
Sell
-14,784
Closed -$2.11M 157
2024
Q2
$2.11M Sell
14,784
-87
-0.6% -$11.5K 0.35% 40
2024
Q1
$1.91M Sell
14,871
-3,671
-20% -$437K 0.33% 39
2023
Q4
$1.92M Buy
18,542
+12,061
+186% +$1.19M 0.37% 40
2023
Q3
$589K Sell
6,481
-10,035
-61% -$884K 0.12% 67
2023
Q2
$1.34M Buy
16,516
+2
+0% +$163 0.27% 46
2023
Q1
$1.31M Buy
16,514
+200
+1% +$14.2K 0.29% 49
2022
Q4
$1.1M Sell
16,314
-5,840
-26% -$342K 0.26% 53
2022
Q3
$1.1M Buy
22,154
+6,060
+38% +$325K 0.28% 48
2022
Q2
$897K Buy
16,094
+10,000
+164% +$555K 0.21% 60
2022
Q1
$338K Sell
6,094
-4,112
-40% -$211K 0.07% 126
2021
Q4
$572K Hold
10,206
0.11% 96
2021
Q3
$490K Buy
10,206
+4,002
+65% +$193K 0.1% 104
2021
Q2
$260K Hold
6,204
0.05% 149
2021
Q1
$209K Sell
6,204
-6,000
-49% -$214K 0.05% 151
2020
Q4
$426K Sell
12,204
-21,200
-63% -$733K 0.1% 104
2020
Q3
$1.16M Buy
33,404
+20,002
+149% +$667K 0.3% 47
2020
Q2
$439K Buy
13,402
+2
+0% +$64 0.13% 91
2020
Q1
$403K Hold
13,400
0.17% 69
2019
Q4
$388K Buy
+13,400
New +$371K 0.1% 91

Other funds holding NVO

King Wealth Management Group's NVO Position: Q1 2025 in Review

King Wealth Management Group sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,379 shares — an estimated $205K sold.

King Wealth Management Group first reported a position in NVO in Q4 2019 and held it in 20 quarters. The position peaked at $2.11M in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • King Wealth Management Group reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • King Wealth Management Group sold 2,379 Novo Nordisk shares in Q1 2025, an estimated $205K.
  • King Wealth Management Group first reported a position in Novo Nordisk in Q4 2019 and held it in 20 quarters.
  • King Wealth Management Group's Novo Nordisk position peaked at $2.11M in Q2 2024.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on King Wealth Management Group's 13F filing for Q1 2025, filed 8 May 2025.